FDA Import Refusal SCS-9860265-1/11/1 — PHARMA TAMAR
The FDA refused shipment SCS-9860265-1/11/1 from PHARMA TAMAR (Israel) on Feb 24, 2022. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75 This firm has 2 other import refusals on record.
Refusal Details
- Date
- Feb 24, 2022
- Country
- Israel
- Product Category
- Drugs and Biologics
- Product Code
- 66VDY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 75